Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Q1 2024 Earnings Call Transcript May 14, 2024
Acumen Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.00025, expectations were $-0.23.
Operator: Good day and thank you for standing by. Welcome to Acumen Pharmaceuticals First Quarter 2024 Conference Call and Webcast. [Operator Instructions] Please be advised that today’s conference is being recorded. I would now like to hand the conference over to your first speaker today, Alex...
